118 related articles for article (PubMed ID: 6759888)
1. [DNA content in Escherichia coli mutants resistant to rifampicin and nalidixic acid].
Korotiaev AI; Krolichenko TP
Mikrobiologiia; 1982; 51(6):983-5. PubMed ID: 6759888
[TBL] [Abstract][Full Text] [Related]
2. [Resistance to nalidixic acid in tetracycline-resistant mutants of E. coli].
Khanina MF; Gromova TG; Terekhov AA
Antibiotiki; 1975; 20(12):1099-104. PubMed ID: 773284
[TBL] [Abstract][Full Text] [Related]
3. [Effect of R plasmids on the DNA content of Escherichia coli].
Korotiaev AI; Krolichenko TP
Antibiotiki; 1982; 27(7):525-7. PubMed ID: 6753733
[TBL] [Abstract][Full Text] [Related]
4. [Production of phage-resistant mutants of E. coli, producers of penicillin acylase].
Romanova NB; Bel'kind AM; Dolgova MI; Golub EI
Antibiotiki; 1976 Jul; 21(7):600-3. PubMed ID: 782351
[TBL] [Abstract][Full Text] [Related]
5. Genetic and physiological investigation of rifampicin-resistant RNA-polymerase mutants of Escherichia coli K-12. Communication I. Study of certain genotypic and phenotypic properties of rifampicin-resistant mutants.
Alikhanyan SI; Tovmasyan KN; Severina IA
Sov Genet; 1974 Sep; 8(10):1296-302. PubMed ID: 4612738
[No Abstract] [Full Text] [Related]
6. [Physiological and biochemical properties of E. coli B/r rifampicin-resistant mutants with pleitropic effects].
Oganesian MG; Arutiunian AV; Ozolin' ON; Kamzolova SG
Dokl Akad Nauk SSSR; 1977 Mar; 233(2):487-90. PubMed ID: 322976
[No Abstract] [Full Text] [Related]
7. Effect of nalidixic acid on recombination and DNA repair of Escherichia coli K-12 strains.
Inan S; Kalaycioglu A
Indian J Exp Biol; 1996 Oct; 34(10):949-53. PubMed ID: 9055644
[TBL] [Abstract][Full Text] [Related]
8. [Mutations of resistance to rifampicin leading to increased activity of the uridine phosphorylase gene in Escherichia coli].
Astvatsaturian MZ; Mironov AS; Sukhodolets VV
Genetika; 1983 Jul; 19(7):1070-4. PubMed ID: 6352408
[TBL] [Abstract][Full Text] [Related]
9. Mutations in gyrA and parC genes in nalidixic acid-resistant Escherichia coli strains from food products, humans and animals.
Sáenz Y; Zarazaga M; Briñas L; Ruiz-Larrea F; Torres C
J Antimicrob Chemother; 2003 Apr; 51(4):1001-5. PubMed ID: 12654733
[TBL] [Abstract][Full Text] [Related]
10. [Mechanisms of onset of quinolone-resistant mutants in E. coli strains].
Matinca D; Serban O
Bacteriol Virusol Parazitol Epidemiol; 2003; 48(2-3):169-70. PubMed ID: 15341335
[No Abstract] [Full Text] [Related]
11. In vivo selection during ofloxacin therapy of Escherichia coli with combined topoisomerase mutations that confer high resistance to ofloxacin but susceptibility to nalidixic acid.
Cattoir V; Lesprit P; Lascols C; Denamur E; Legrand P; Soussy CJ; Cambau E
J Antimicrob Chemother; 2006 Nov; 58(5):1054-7. PubMed ID: 16984897
[TBL] [Abstract][Full Text] [Related]
12. Are quinolone-resistant uropathogenic Escherichia coli less virulent?
Vila J; Simon K; Ruiz J; Horcajada JP; Velasco M; Barranco M; Moreno A; Mensa J
J Infect Dis; 2002 Oct; 186(7):1039-42. PubMed ID: 12232848
[TBL] [Abstract][Full Text] [Related]
13. Studies on mutational cross-resistance between ciprofloxacin, novobiocin and coumermycin in Escherichia coli and Staphylococcus warneri.
Howard BM; Pinney RJ; Smith JT
Microbios; 1993; 75(304):185-95. PubMed ID: 8246811
[TBL] [Abstract][Full Text] [Related]
14. Nitrofurantoin resistance mechanism and fitness cost in Escherichia coli.
Sandegren L; Lindqvist A; Kahlmeter G; Andersson DI
J Antimicrob Chemother; 2008 Sep; 62(3):495-503. PubMed ID: 18544599
[TBL] [Abstract][Full Text] [Related]
15. Types of spontaneous nalidixic acid resistant mutants of Escherichia coli.
Kumar S
Indian J Exp Biol; 1980 Apr; 18(4):341-3. PubMed ID: 6995285
[No Abstract] [Full Text] [Related]
16. Genetic and physiological investigation of rifampicin-resistant RNA polymerase mutants of Escherichia coli K-12. Communication II. Localization of the rifampicin locus on the chromosome map and its fine mapping.
Alikhanyan SI; Tovmasyan KN
Sov Genet; 1974 Nov; 9(1):52-6. PubMed ID: 4616345
[No Abstract] [Full Text] [Related]
17. [Effect of the action of nalidixic acid on the submicroscoic structure of bacteria].
Kats LN; Andreeva AM; Moroz AF
Antibiotiki; 1968 Sep; 13(9):841-5. PubMed ID: 4884476
[No Abstract] [Full Text] [Related]
18. [Disturbance in the equilibrium between DNA and protein synthesis rates in bacteria and their viability].
Fradkin GE; Aĭzenberg OA; Samoĭlenko II
Mikrobiologiia; 1975; 44(4):592-4. PubMed ID: 1100996
[TBL] [Abstract][Full Text] [Related]
19. [Flavinogenesis regulation in riboflavin-dependent Escherichia coli mutants].
Shavlovskiĭ GM; Tesliar GE; Strugovshchikova LP
Mikrobiologiia; 1982; 51(6):986-92. PubMed ID: 6759889
[TBL] [Abstract][Full Text] [Related]
20. Mutators among CTX-M beta-lactamase-producing Escherichia coli and risk for the emergence of fosfomycin resistance.
Ellington MJ; Livermore DM; Pitt TL; Hall LM; Woodford N
J Antimicrob Chemother; 2006 Oct; 58(4):848-52. PubMed ID: 16891630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
